Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

计划入组 3 人 · 首次发布于 2019 年 12 月 24 日

Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

计划入组 16 人 · 首次发布于 2009 年 4 月 1 日

Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

计划入组 105 人 · 首次发布于 1999 年 11 月 4 日

Venetoclax(Venclexta, Venclyxto)

C₄₅H₅₀ClN₇O₇S · Rx

Oncoquest-CLL

Acalabrutinib(Calquence)

C₂₆H₂₃N₇O₂ · Rx

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

Kineta Chronic Pain LLC

United States

A&A SMALL CHANGES HANDYPEOPLE

United States

Lilly's Jaypirca Shows Promise in BTK Inhibitor-Pretreated CLL/SLL

Glenmark Pharmaceuticals Receives DCGI Approval to Launch BRUKINSA for Five B-Cell Malignancies in India

FDA Grants Expanded Approval for Eli Lilly's Jaypirca in Earlier-Line CLL/SLL Treatment